Recon Strategy
Contact

CASE STUDY

/

Molecular diagnostics growth strategy

A molecular diagnostics developer had more new-test opportunities than it could fund and no shared view of which it was equipped to win or whether the economics could work.

B743-124

Test developer landscape mapped to locate white space

Situation

Pipeline ambition, but no prioritization

  • Client sought evaluation of growth strategy to successfully develop and commercialize new molecular diagnostic tests.
  • Remit of potential opportunities was broad, including next gen cancer diagnostics, rare disease testing and polygenic scoring.
  • Strategy evaluation included external evaluation of diagnostics market, assessment of internal capabilities compared to competitors and necessary investment to enter new market segments.

Project

Capability gap and P&L modeling

  • Conducted market landscape analysis of test-developer to help identify market need, specific opportunities and necessary capabilities.
  • Delineated capabilities required for product development and commercialization and an inside-out capability-gap assessment identifying key areas for organizational building.
  • Built a bottom-up financial model including development cost and revenue projections, covering multiple potential P&L scenarios based on prioritized opportunities.

Client readiness assessed across full development pathway

Bottom-up P&L built to support board decision

Outcome

Prioritized path, partnered execution

  • Recommended path forward with an actionable plan and board-ready materials, complete with specific investments and projected bottom-line impact.
  • Organization has implemented a set of the prioritized opportunities, establishing partnerships with key industry players to accelerate path.

MORE CASE STUDIES

Related work

  • Institutional

Strategy for Statewide Health Information Exchange

A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable

HIE, Health IT,

  • Medtech, Early Stage

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

  • Institutional

University Trials

Large university wanting to dramatically increase its clinical research footprint

See all case studies